251930-53-7

Basic information

• Product Name: methyl 6-(4-fluorophenyl)-2-methoxy-4-methyl-1,6-dihydro-5-pyrimidinecarboxylate
• Synonyms: methyl 6-(4-fluorophenyl)-2-methoxy-4-methyl-1,6-dihydro-5-pyrimidinecarboxylate
• CAS NO: 251930-53-7
• Molecular Weight: 278.283
• Mol File: 251930-53-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: methyl 6-(4-fluorophenyl)-2-methoxy-4-methyl-1,6-dihydro-5-pyrimidinecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 6-(4-fluorophenyl)-2-methoxy-4-methyl-1,6-dihydro-5-pyrimidinecarboxylate(251930-53-7)
• EPA Substance Registry System: methyl 6-(4-fluorophenyl)-2-methoxy-4-methyl-1,6-dihydro-5-pyrimidinecarboxylate(251930-53-7)

Safety Data

• Hazardous Substances Data: 251930-53-7(Hazardous Substances Data)

Upstream product

• 29427-58-5 O-methylisourea hemisulfate 
• 111556-82-2 2-[1-(4-Fluoro-phenyl)-meth-(Z)-ylidene]-3-oxo-butyric acid methyl ester 
• 105-45-3 acetoacetic acid methyl ester 
• 459-57-4 4-fluorobenzaldehyde 

Downstream Products

• 251930-61-7 6-(4-fluorophenyl)-1,6-dihydro-2-methoxy-5-methoxycarbonyl-4-methyl-1-[(4-nitrophenyloxy)carbonyl]pyrimidine 
• 1027830-00-7 6-(4-fluoro-phenyl)-2-methoxy-1-[3-(4-methoxycarbonyl-4-phenyl-piperidin-1-yl)-propylcarbamoyl]-4-methyl-1,6-dihydro-pyrimidine-5-carboxylic acid methyl ester 

Relevant articles and documents

SECONDARY AMINO ANILINIC PIPERIDINES AS MCH1 ANTAGONISTS AND USES THEREOF

This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compounds of the invention and a pharmaceutically acceptable carrier. This invention also provides a method of reducing the body mass of a subject which comprises administering to the subject an amount of a compound of the invention effective to reduce the body mass of the subject. This invention further provides a method of treating a subject suffering from depression and/or anxiety which comprises administering to the subject an amount of a compound of the invention effective to treat the subject=s depression and/or anxiety. This invention further provides a method of treating a subject suffering from a urinary disorder.